Demyelinating optic neuritis presenting as a clinically isolated syndrome

Optometry

Volumn 83, Issue 1, 2012, Pages 9-18

  Holdeman, Nicky R ^a   Nguyen, Tammy ^a   Tang, Rosa A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Clinically isolated syndrome; Demyelination; Immunomodulators; Magnetic resonance imaging; Multiple sclerosis; Optic neuritis; Optical coherence tomography

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PATHOLOGY; SYNDROME; VISUAL ACUITY;

ADULT; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; SYNDROME; VISUAL ACUITY;

EID: 83255192246     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2011.10.010     Document Type: Article

References (14)

1. Polman C.H., Reingold S.C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302.
2. Pelidou S.H., Giannopoulos S., Tzavidi S., et al. Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment. Ther Clin Risk Manag 2008, 4:627-630.
3. Guercio J.R., Balcer L.J. Inflammatory optic neuropathies and neuroretinitis. Ophthalmology 2009, 964-969. Mosby Elsevier, Edinburgh. 3rd ed. M. Yanoff, J.S. Duker (Eds.).
4. Shams P.N., Plant G.T. Optic neuritis: A review. Int MS J 2009, 16:82-89.
5. Rodriguez M., Siva A., Cross S.A., et al. Optic neuritis: A population-based study in Olmstead County, Minnesota. Neurology 1995, 45:244-250.
6. Chu E.R., Chen C.S. Optic neuritis-more than a loss of vision. Aust Fam Physician 2009, 38:789-793.
7. Dalton C.M., Brex P.A., Miszkiel K.A., et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002, 52:47-53.
8. Traboulsee A.L., Li D.K. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol 2006, 98:125-146.
9. Wattjes M.P., Harzheim M., Kuhl C.K., et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR Imaging criteria for multiple sclerosis?. Am J Neuroradiol 2006, 27:1794-1798.
10. Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up. Arch Neurol 2008, 65:727-732. Optic Neuritis Study Group.
11. Henderson A.P., Trip S.A., Schlottmann P.G., et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008, 131(Pt 1):277-287.
12. Sergott R.C., Frohman E., Glanzman R., et al. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007, 263:3-14. OCT in MS Expert Panel.
13. Talman L.S., Bisker E.R., Sackel D.J., et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010, 67:749-760.
14. Burkholder B.M., Osborne B., Loguidice M.J., et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 2009, 66:1366-1372.